Cargando…

HPLC Method Development for Quantification of Doxorubicin in Cell Culture and Placental Perfusion Media

Assessment of drug transport across the placenta is important in understanding the effect of drugs on placental and fetal health. These phenomena can be studied in both in vitro cell lines and ex vivo placental perfusions. We have successfully developed a sensitive yet simple high performance liquid...

Descripción completa

Detalles Bibliográficos
Autores principales: Shah, Mansi, Bourner, Luke, Ali, Shariq, Al-Enazy, Sanaalarab, Youssef, Menatallah M., Fisler, Morgan, Rytting, Erik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6035002/
https://www.ncbi.nlm.nih.gov/pubmed/29984222
http://dx.doi.org/10.3390/separations5010009
_version_ 1783337976759058432
author Shah, Mansi
Bourner, Luke
Ali, Shariq
Al-Enazy, Sanaalarab
Youssef, Menatallah M.
Fisler, Morgan
Rytting, Erik
author_facet Shah, Mansi
Bourner, Luke
Ali, Shariq
Al-Enazy, Sanaalarab
Youssef, Menatallah M.
Fisler, Morgan
Rytting, Erik
author_sort Shah, Mansi
collection PubMed
description Assessment of drug transport across the placenta is important in understanding the effect of drugs on placental and fetal health. These phenomena can be studied in both in vitro cell lines and ex vivo placental perfusions. We have successfully developed a sensitive yet simple high performance liquid chromatography (HPLC) method coupled with fluorescence detection to determine the concentration of doxorubicin (DXR) in cell culture media for transport studies in human trophoblast cells (BeWo, b30 clone) and in fetal media for placental perfusion experiments. The method was developed based on a protein precipitation technique and was validated in both media types for linearity, intra-day, and inter-day precision and accuracy. The relationship of peak area to concentration was linear with R(2) values of 0.99 or greater obtained over the concentration range of 1.5 to 15,000 ng/mL. Despite the high concentrations of albumin in fetal perfusion media (30 mg/mL), the lower limits of detection and quantification for DXR were found to be 1.5 and 5 ng/mL, respectively. This analytical method may be used to study the transport of DXR across BeWo cells and human placenta during placental perfusion studies.
format Online
Article
Text
id pubmed-6035002
institution National Center for Biotechnology Information
language English
publishDate 2018
record_format MEDLINE/PubMed
spelling pubmed-60350022018-07-06 HPLC Method Development for Quantification of Doxorubicin in Cell Culture and Placental Perfusion Media Shah, Mansi Bourner, Luke Ali, Shariq Al-Enazy, Sanaalarab Youssef, Menatallah M. Fisler, Morgan Rytting, Erik Separations Article Assessment of drug transport across the placenta is important in understanding the effect of drugs on placental and fetal health. These phenomena can be studied in both in vitro cell lines and ex vivo placental perfusions. We have successfully developed a sensitive yet simple high performance liquid chromatography (HPLC) method coupled with fluorescence detection to determine the concentration of doxorubicin (DXR) in cell culture media for transport studies in human trophoblast cells (BeWo, b30 clone) and in fetal media for placental perfusion experiments. The method was developed based on a protein precipitation technique and was validated in both media types for linearity, intra-day, and inter-day precision and accuracy. The relationship of peak area to concentration was linear with R(2) values of 0.99 or greater obtained over the concentration range of 1.5 to 15,000 ng/mL. Despite the high concentrations of albumin in fetal perfusion media (30 mg/mL), the lower limits of detection and quantification for DXR were found to be 1.5 and 5 ng/mL, respectively. This analytical method may be used to study the transport of DXR across BeWo cells and human placenta during placental perfusion studies. 2018-01-24 2018-03 /pmc/articles/PMC6035002/ /pubmed/29984222 http://dx.doi.org/10.3390/separations5010009 Text en http://creativecommons.org/licenses/by/4.0/ Submitted for possible open access publication under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Shah, Mansi
Bourner, Luke
Ali, Shariq
Al-Enazy, Sanaalarab
Youssef, Menatallah M.
Fisler, Morgan
Rytting, Erik
HPLC Method Development for Quantification of Doxorubicin in Cell Culture and Placental Perfusion Media
title HPLC Method Development for Quantification of Doxorubicin in Cell Culture and Placental Perfusion Media
title_full HPLC Method Development for Quantification of Doxorubicin in Cell Culture and Placental Perfusion Media
title_fullStr HPLC Method Development for Quantification of Doxorubicin in Cell Culture and Placental Perfusion Media
title_full_unstemmed HPLC Method Development for Quantification of Doxorubicin in Cell Culture and Placental Perfusion Media
title_short HPLC Method Development for Quantification of Doxorubicin in Cell Culture and Placental Perfusion Media
title_sort hplc method development for quantification of doxorubicin in cell culture and placental perfusion media
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6035002/
https://www.ncbi.nlm.nih.gov/pubmed/29984222
http://dx.doi.org/10.3390/separations5010009
work_keys_str_mv AT shahmansi hplcmethoddevelopmentforquantificationofdoxorubicinincellcultureandplacentalperfusionmedia
AT bournerluke hplcmethoddevelopmentforquantificationofdoxorubicinincellcultureandplacentalperfusionmedia
AT alishariq hplcmethoddevelopmentforquantificationofdoxorubicinincellcultureandplacentalperfusionmedia
AT alenazysanaalarab hplcmethoddevelopmentforquantificationofdoxorubicinincellcultureandplacentalperfusionmedia
AT youssefmenatallahm hplcmethoddevelopmentforquantificationofdoxorubicinincellcultureandplacentalperfusionmedia
AT fislermorgan hplcmethoddevelopmentforquantificationofdoxorubicinincellcultureandplacentalperfusionmedia
AT ryttingerik hplcmethoddevelopmentforquantificationofdoxorubicinincellcultureandplacentalperfusionmedia